AlterEcho develops remote embodiment robotics that let operators control robotic arms in sterile or hazardous environments without being physically present. Using immersive interfaces, users perform precise tasks from a safe location, avoiding direct contact with contamination-sensitive areas. We target critical life science fields where human presence is a liability but intervention is essential, such as radiopharmaceuticals, infectious diseases, viral vector vaccines, cell and gene therapy, sterile compounding, and aseptic filling. These domains require precision, adaptability, and compliance across both laboratory and production settings. AlterEcho is a software-first, hardware-agnostic platform that integrates with standard robotic systems and infrastructure. By enabling seamless, immersive control without custom hardware, we reduce risk, protect operators, and improve consistency without disrupting existing workflows. We begin in controlled laboratory environments and scale toward high-throughput pharmaceutical manufacturing. Support from Innovation Fund Denmark enables us to complete our physical prototype, validate performance in biosafety settings, and launch pilot collaborations. Long term, the data collected through AlterEcho will train embodied AI systems - powering a future of autonomous cleanroom chambers that replicate expert intervention safely and reliably - always supervised by humans and manually controlled when needed.

AM-Farm will set up the first Danish photopolymerization based Additive Manufacturing (AM) Farm that will cater to agile intermediate-sized production (1000-100,000 components) that can surpass injection molding in agility, and volumetric specific energy consumption (kJ/cm3). While injection molding is highly efficient at scale (>MM components), the energy consumption and tooling costs make it unattractive for intermediate-sized production. AM-Farm is thus the establishment of an autonomous industrial AM facility with an unrivaled productivity, bespoke mass production capability and built on multiple cardinal sustainable innovations. Vat photopolymerization AM (VPP) is the method that is unsurpassed in its capability to produce plastic components at the highest geometrical fidelity. It has revolutionized how bespoke and miniaturized components such as hearing aid shells are manufactured. While in many aspects, an ideal next generation manufacturing process, the wide industrial implementation has been deterred due to considerate amounts of chemical waste generated. AM-Farm congregates a consortium, empowered by new technological advances spun out of academia to set up the world’s first environmentally conscious facility to fully exploit the potential of VPP. The industrial partners aim to exploit the AM-Farm, internally as a next-generation manufacturing method, and as a profitable service available to other Danish manufacturers for intermediate-sized bespoke production.